Page last updated: 2024-09-03

lysyl-aspartyl-glutamyl-leucine and Invasiveness, Neoplasm

lysyl-aspartyl-glutamyl-leucine has been researched along with Invasiveness, Neoplasm in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cohen, M; Delie, F; Petignat, P; Ribaux, P1
Abad, JL; Bernad, A; Gómez-Moutón, C; González, MA; Lacalle, RA; Mañes, S; Martínez-A, C; Mira, E1

Other Studies

2 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and Invasiveness, Neoplasm

ArticleYear
Anti-KDEL-coated nanoparticles: a promising tumor targeting approach for ovarian cancer?
    Biochimie, 2012, Volume: 94, Issue:11

    Topics: Antibodies, Monoclonal; Apoptosis; Cell Line, Tumor; Endoplasmic Reticulum Chaperone BiP; Female; Gene Expression Regulation, Neoplastic; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Membrane Proteins; Molecular Targeted Therapy; Nanoparticles; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Paclitaxel; Protein Sorting Signals

2012
A role for chemokine receptor transactivation in growth factor signaling.
    EMBO reports, 2001, Volume: 2, Issue:2

    Topics: Breast Neoplasms; Cell Polarity; Chemokine CCL5; Chemotaxis; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Insulin-Like Growth Factor I; Ligands; Mutation; Neoplasm Invasiveness; Oligopeptides; Phosphorylation; Protein Sorting Signals; Receptors, CCR5; RNA, Messenger; Signal Transduction; Transcriptional Activation; Tumor Cells, Cultured

2001